Primary Effusion Lymphoma: Clinical Trials

5 trials for Primary Effusion Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 withdrawn. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Recruiting 2, Withdrawn 1
Phase 23Completed 2, Withdrawn 1

Follow Primary Effusion Lymphoma: new trials by email Literature Review of Primary Effusion Lymphoma trials Research Report on Primary Effusion Lymphoma

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1RecruitingNational Cancer Institute (NCI)152027-07-052026-11-05
Study of SGR-1505 in Mature B-Cell Neoplasms
SGR-1505 - Mature B-Cell Neoplasm, Non Hodgkin Lymphoma
Phase 1RecruitingSchrödinger, Inc.982023-04-102026-02-13
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
Lenalidomide, Rituximab, Prednisone - Primary Effusion Lymphoma, B-Cell Neoplasm
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)172017-07-032026-11-12
Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
Pomalidomide, Rituximab, Prednisone - Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease, Primary Effusion Lymphoma
Phase 1 / Phase 2WithdrawnNational Cancer Institute (NCI)2014-08-152018-08-31
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)1072010-10-062023-11-21

Narrower conditions

Lymphoma, Primary Effusion (5)  ·  Plasmablastic Lymphoma (3)  ·  Lymphoma, Follicular (2)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Burkitt Lymphoma (1)  ·  HIV Infections (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, AIDS-Related (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Pyloric Stenosis, Hypertrophic (1)  ·  Waldenstrom Macroglobulinemia (1)

Broader conditions

Hemic and Lymphatic Diseases (5)  ·  Immune System Diseases (5)  ·  Immunoproliferative Disorders (5)  ·  Lymphatic Diseases (5)  ·  Lymphoma (5)  ·  Lymphoproliferative Disorders (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Lymphoma, B-Cell (4)  ·  Lymphoma, Non-Hodgkin (4)  ·  Infections (2)  ·  Virus Diseases (2)  ·  Blood Protein Disorders (1)  ·  Blood-Borne Infections (1)  ·  Cardiovascular Diseases (1)

Interventions

Cyclophosphamide (4)  ·  Doxorubicin (4)  ·  Prednisone (4)  ·  Rituximab (4)  ·  Vincristine (4)  ·  Etoposide (3)  ·  CT-P10 (2)  ·  deltacortene (2)  ·  prednylidene (2)  ·  Biopsy (1)  ·  Bronchoscopy (1)  ·  Echocardiography (1)  ·  Electrocardiography (1)  ·  Endoscopy (1)  ·  Lenalidomide (1)

Sponsors

National Cancer Institute (NCI) (4)  ·  Schrödinger, Inc. (1)

Countries

United States (4)  ·  France (1)  ·  Italy (1)  ·  Moldova (1)  ·  Poland (1)  ·  Romania (1)  ·  Spain (1)  ·  Ukraine (1)

Top investigators

Frank G Basile, M.D. (1)  ·  Juan C Ramos (1)  ·  Ramya Ramaswami, MBBS, MPH (1)  ·  Stefan K Barta (1)  ·  Thomas S Uldrick, M.D. (1)

Results publications

PMID 32430507

NIH funding

UM1CA121947 (2)